Cargando…

Interleukin‐2‐inducible Killer Activity and Its Regulation by Blood Monocytes from Autologous Lymphocytes of Lung Cancer Patients

The ability of blood lymphocytes of newly diagnosed lung cancer patients to respond to interleukin 2 (IL‐2) to become IL‐2‐activated killer (LAK) cells and its regulation by autologous monocytes were examined. LAK activity was measured by (31)Cr release assay. The abilities of lymphocytes among bloo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sone, Saburo, Kunishige, Eiji, Fawzy, Farid, Yanagawa, Hiroaki, Nil, Akihiko, Maeda, Ken‐ichi, Atagi, Shinji, Heike, Yuji, Nishioka, Yasuhiko, Mizuno, Kazuhito, Ogura, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1991
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918506/ https://www.ncbi.nlm.nih.gov/pubmed/1649813 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01908.x

Ejemplares similares

Inhibition by Fibrin Coagulation of Lung Cancer Cell Destruction by Human Interleukin‐2‐activated Killer Cells
por: Atagi, Shinji, et al.
Publicado: (1992)

Suppression by Interleukin 4 of Activation of Human Blood Monocytes to the Tumoricidal State
por: Nishioka, Yasuhiko, et al.
Publicado: (1990)

Lymphokine‐activated Killer Induction and Its Regulation by Macrophages in Malignant Pleural Effusions
por: Yanagawa, Hiroaki, et al.
Publicado: (1989)

Anti‐ganglioside GM(2) Monoclonal Antibody‐dependent Killing of Human Lung Cancer Cells by Lymphocytes and Monocytes
por: Hanibuchi, Masaki, et al.
Publicado: (1996)

Induction Mechanism of Human Blood CD8(+) T Cell Proliferation and Cytotoxicity by Natural Killer Cell Stimulatory Factor (Interleukin‐12)
por: Nabioullin, Roustem, et al.
Publicado: (1994)

Human Alveolar Macrophages Augment Natural Killer Cell Stimulatory Factor (Interleukin‐12)‐inducible Killer Activity from Autologous Blood Lymphocytes
por: Haku, Takashi, et al.
Publicado: (1995)

Killing of Alveolar Macrophages and of Monocytes that Have Responded to Granulocyte‐Macrophage Colony‐stimulating Factor by Human Lymphokine‐activated Killer Cells
por: Sone, Saburo, et al.
Publicado: (1989)

Cyclosporin A Enhances Susceptibility of Multi‐drug Resistant Human Cancer Cells to Anti‐P‐glycoprotein Antibody‐dependent Cytotoxicity of Monocytes, but Not of Lymphocytes
por: Yano, Seiji, et al.
Publicado: (1994)

Induction by Interleukin‐15 of Human Killer Cell Activity against Lung Cancer Cell Lines and Its Regulatory Mechanisms
por: Takeuchi, Eiji, et al.
Publicado: (1996)

Effector Cell Analysis of Human Multidrug‐resistant Cell Killing by Mouse‐Human Chimeric Antibody against P‐Glycoprotein
por: Nishioka, Yasuhiko, et al.
Publicado: (1992)

Enhancement of Therapeutic Effect of Interleukin‐2 on Spontaneous Pulmonary Metastases of Lewis Lung Carcinoma by Killer Helper Factor Associated with Increased Induction of Killer Activity
por: Fukuta, Katsuyuki, et al.
Publicado: (1989)

Autonomous Expressions of Cytokine Genes by Human Lung Cancer Cells and Their Paracrine Regulation
por: Mizuno, Kazuto, et al.
Publicado: (1994)

Potential Value of Cetylmannoside‐modified Liposomes as Carriers of Macrophage Activators to Human Blood Monocytes
por: Yamashita, Chikamasa, et al.
Publicado: (1991)

Enhancement by Monocytes of Perform Production and Its Gene Expression by Human CD8+ T Cells Stimulated with Interleukin‐2
por: Sugihara, Kohji, et al.
Publicado: (1992)

Murine Typhus from Vietnam, Imported into Japan
por: Azuma, Momoyo, et al.
Publicado: (2006)

Transduction of the Macrophage Colony‐stimulating Factor Gene into Human Multidrug Resistant Cancer Cells: Enhanced Therapeutic Efficacy of Monoclonal Anti‐P‐glycoprotein Antibody in Nude Mice
por: Sone, Saburo, et al.
Publicado: (1996)

Granulocyte‐Macrophage Colony‐stimulating Factor Augments Lymphokine‐activated Killer Activity from Pleural Cavity Mononuclear Cells of Lung Cancer Patients without Malignant Effusion
por: Takahashi, Keiji, et al.
Publicado: (1995)

A New Quinoline Derivative MS‐209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P‐glycoprotein‐expressing Human Small Cell Lung Cancer Cells
por: Nokihara, Hiroshi, et al.
Publicado: (2001)

Monoclonal Anti‐P‐glycoprotein Antibody‐dependent Killing of Multidrug‐resistant Tumor Cells by Human Mononuclear Cells
por: Heike, Yuji, et al.
Publicado: (1990)

The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice
por: Van, Trung The, et al.
Publicado: (2010)

Early Growth Response 4 Is Involved in Cell Proliferation of Small Cell Lung Cancer through Transcriptional Activation of Its Downstream Genes
por: Matsuo, Taisuke, et al.
Publicado: (2014)

Augmentation of Human Cytotoxic T Lymphocytes against Autologous Tumor by a Factor Released from Human Monocytic Leukemia Cell Line
por: Maeda, Nagamasa, et al.
Publicado: (1989)

Production of Tumor Necrosis Factor‐α by Alveolar Macrophages of Lung Cancer Patients
por: Okubo, Akio, et al.
Publicado: (1990)

Comparative analysis of interleukin 15 and interleukin 2 for induction of killer activity and of type 2 cytokine production by mononuclear cells from lung cancer patients.
por: Takeuchi, E., et al.
Publicado: (1998)

Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice
por: Sato, Seidai, et al.
Publicado: (2015)

Serum levels of interleukin 6 in patients with lung cancer.
por: Yanagawa, H., et al.
Publicado: (1995)

Characterization of the killer cell generated in the autologous mixed leukocyte reaction
Publicado: (1983)

A Case of Severe Aortic Stenosis after Aortic Valve Neocuspidization Using Autologous Pericardium (Ozaki Procedure)
por: Mikami, Takuma, et al.
Publicado: (2022)

Consequences of the crosstalk between monocytes/macrophages and natural killer cells
por: Michel, Tatiana, et al.
Publicado: (2013)

Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
por: Takeuchi, Eiji, et al.
Publicado: (2022)

Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors
por: Takeuchi, Eiji, et al.
Publicado: (2023)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations
por: Kunishige, Michihiro, et al.
Publicado: (2023)

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2018)

Autologous Enhancement by Interferon of Natural Killer Activity of Human Peripheral Blood Lymphocytes
por: Cheknev, S. B., et al.
Publicado: (1994)

Natural Killer Cell–mediated Lysis of Autologous Cells Modified by Gene Therapy
por: Liberatore, Concetta, et al.
Publicado: (1999)

CD13/aminopeptidase N in collagen vascular diseases
por: Dan, Hirohumi, et al.
Publicado: (2003)

Giant adrenal pseudocyst removed using robot‐assisted surgery
por: Ohzeki, Takayuki, et al.
Publicado: (2023)

Oligonucleotide Sequences Required for Natural Killer Cell Activation
por: Kuramoto, Etsuro, et al.
Publicado: (1992)

Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells
por: Godiska, Ronald, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_8h1d81hjcmnuiddc40b05jb8uq